06/11/2025
4:04 PM | Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2025
12:02 PM | Collegium Pharmaceutical (Subject)
Freund John Gordon (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2025
3:32 PM | Collegium Pharmaceutical (Filer)
| Form S-8 POS | |
06/06/2025
3:32 PM | Collegium Pharmaceutical (Filer)
| Form S-8 POS | |
06/06/2025
3:32 PM | Collegium Pharmaceutical (Filer)
| Form S-8 POS | |
06/06/2025
3:33 PM | Collegium Pharmaceutical (Filer)
| Form S-8 POS | |
06/06/2025
3:33 PM | Collegium Pharmaceutical (Filer)
| Form S-8 POS | |
06/06/2025
3:34 PM | Collegium Pharmaceutical (Filer)
| Form S-8 POS | |
06/06/2025
3:34 PM | Collegium Pharmaceutical (Filer)
| Form S-8 POS | |
06/06/2025
3:34 PM | Collegium Pharmaceutical (Filer)
| Form S-8 POS | |
06/06/2025
3:34 PM | Collegium Pharmaceutical (Filer)
| Form S-8 POS | |
Get the Latest News and Ratings for COLL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Collegium Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. |
06/06/2025
3:35 PM | Collegium Pharmaceutical (Filer)
| Form S-8 POS | |
05/19/2025
4:35 PM | Collegium Pharmaceutical (Issuer)
Paya Carlos V (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/19/2025
4:37 PM | Collegium Pharmaceutical (Issuer)
Paya Carlos V (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:39 PM | Collegium Pharmaceutical (Issuer)
SANTINI GINO (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:42 PM | Collegium Pharmaceutical (Issuer)
Freund John Gordon (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:42 PM | Balice-Gordon Rita J. (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:42 PM | BOHLIN GAREN G (Reporting)
Collegium Pharmaceutical (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:43 PM | Collegium Pharmaceutical (Issuer)
Lurker Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:43 PM | Collegium Pharmaceutical (Issuer)
Fallon John A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2025
7:10 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2025
10:04 AM | Collegium Pharmaceutical (Subject)
Pacer Advisors, Inc. (Filed by)
| Form SCHEDULE 13G/A | |
05/02/2025
9:33 AM | Collegium Pharmaceutical (Subject)
Pacer Advisors, Inc. (Filed by)
| Form SCHEDULE 13G | |
04/28/2025
6:56 AM | BlackRock, Inc. (Filed by)
Collegium Pharmaceutical (Subject)
| Form SCHEDULE 13G/A | |
03/24/2025
4:05 PM | Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
4:06 PM | Collegium Pharmaceutical (Issuer)
Tupper Colleen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
3:35 PM | Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/21/2025
3:21 PM | Collegium Pharmaceutical (Subject)
Dreyer Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2025
3:32 PM | Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2025
3:17 PM | Collegium Pharmaceutical (Subject)
Dreyer Scott (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2025
3:19 PM | Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2025
3:34 PM | Collegium Pharmaceutical (Issuer)
Dieter David (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/19/2025
3:36 PM | Collegium Pharmaceutical (Issuer)
Dieter David (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
6:18 PM | Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
| Form 4/A | |
03/18/2025
4:34 PM | Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2025
4:35 PM | Collegium Pharmaceutical (Issuer)
Tupper Colleen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
6:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2025
3:49 PM | Collegium Pharmaceutical (Issuer)
Tupper Colleen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2025
3:50 PM | Collegium Pharmaceutical (Issuer)
Dreyer Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2025
3:13 PM | Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025
5:48 PM | Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump’s Exec Order #14154 could be a “Millionaire-Maker” (Ad) Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans a chance at true financial independence in the months ahead.”
We recently sat down with Rickards to capture all the key details on tape.
 For the moment, you can watch this interview free of charge – just click here. |
03/06/2025
3:43 PM | Collegium Pharmaceutical (Subject)
Tupper Colleen (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2025
3:05 PM | Collegium Pharmaceutical (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/06/2025
9:42 AM | Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2025
2:03 PM | Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025
3:01 PM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/27/2025
3:03 PM | Collegium Pharmaceutical (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/07/2025
12:21 PM | Collegium Pharmaceutical (Subject)
Invesco Ltd. (Filed by)
| Form SCHEDULE 13G | |
02/05/2025
4:30 PM | Collegium Pharmaceutical (Issuer)
Lurker Nancy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/05/2025
4:30 PM | Collegium Pharmaceutical (Issuer)
Lurker Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2025
7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/14/2025
3:12 PM | Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2025
7:05 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:50 PM | Collegium Pharmaceutical (Issuer)
Karnani Vikram (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
4:13 PM | Collegium Pharmaceutical (Subject)
PRINCIPAL GLOBAL INVESTORS (Filed by)
| Form SC 13G | |
11/13/2024
3:30 PM | Collegium Pharmaceutical (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
11/13/2024
1:39 PM | Collegium Pharmaceutical (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
| Form SCHEDULE 13G | |
09/17/2024
3:32 PM | Collegium Pharmaceutical (Issuer)
Smith Thomas B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
9:39 AM | Collegium Pharmaceutical (Subject)
Smith Thomas B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
9:06 AM | Collegium Pharmaceutical (Subject)
Smith Thomas B (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/06/2024
4:52 PM | Collegium Pharmaceutical (Issuer)
Kuhlmann Shirley R. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2024
10:53 AM | Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024
3:47 PM | Collegium Pharmaceutical (Subject)
Kuhlmann Shirley R. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
7:03 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/12/2024
1:41 PM | Collegium Pharmaceutical (Subject)
McFarlane Neil F. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/09/2024
3:34 PM | Collegium Pharmaceutical (Subject)
McFarlane Neil F. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/29/2024
5:02 AM | Collegium Pharmaceutical (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
